While the National Pharmaceutical Pricing Authority (NPPA) revised the ceiling price on coronary stents on Monday, its Chairman Bhupendra Singh stated on ... For me, in my scheme of things, price control is the last (option),” Singh stated at the 'India Pharma 2018' exhibition in Bengaluru on Friday.
Read more: Price control not the best way to achieve affordability: NPPA Chairman Bhupendra Singh